Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease
Y Li, S Lin, Z Gu, L Chen, B He - Bioorganic & Medicinal Chemistry Letters, 2022 - Elsevier
Alzheimer's disease (AD) as the most prevalent dementia type has become one of the
greatest threats to the health and life of the elder people worldwide. Although there has …
greatest threats to the health and life of the elder people worldwide. Although there has …
The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease
SN Batchu, AS Brijmohan, A Advani - Clinical science, 2016 - portlandpress.com
Recent years have witnessed an emergence of a new class of therapeutic agents, termed
histone deacetylase 6 (HDAC6) inhibitors. HDAC6 is one isoform of a family of HDAC …
histone deacetylase 6 (HDAC6) inhibitors. HDAC6 is one isoform of a family of HDAC …
Acetylation of intrinsically disordered regions regulates phase separation
Liquid–liquid phase separation (LLPS) of proteins containing intrinsically disordered regions
(IDRs) has been proposed as a mechanism underlying the formation of membrane-less …
(IDRs) has been proposed as a mechanism underlying the formation of membrane-less …
An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
Tauopathies including Alzheimer's disease (AD) are marked by the accumulation of
aberrantly modified tau proteins. Acetylated tau, in particular, has recently been implicated in …
aberrantly modified tau proteins. Acetylated tau, in particular, has recently been implicated in …
Attenuation of NLRP3 inflammasome activation by indirubin-derived PROTAC targeting HDAC6
Z Cao, Z Gu, S Lin, D Chen, J Wang, Y Zhao… - ACS Chemical …, 2021 - ACS Publications
Histone deacetylase 6 (HDAC6) is a potential therapeutic target for treating several
diseases. A recent study revealed that HDAC6 is important for NLRP3 inflammasome …
diseases. A recent study revealed that HDAC6 is important for NLRP3 inflammasome …
Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly
J Ran, Y Yang, D Li, M Liu, J Zhou - Scientific reports, 2015 - nature.com
Cilia play important roles in sensing extracellular signals and directing fluid flow. Ciliary
dysfunction is associated with a variety of diseases known as ciliopathies. Histone …
dysfunction is associated with a variety of diseases known as ciliopathies. Histone …
Aggregation of the nucleic acid–binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation
TAR DNA-binding protein 43 (TDP-43) is a nucleic acid–binding protein, and its aggregation
represents the defining pathology in amyotrophic lateral sclerosis (ALS) and related …
represents the defining pathology in amyotrophic lateral sclerosis (ALS) and related …
Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1, 3, 4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism
Histone deacetylase 6 (HDAC6) is a unique member of the HDAC family mainly targeting
cytosolic nonhistone substrates, such as α-tubulin, cortactin, and heat shock protein 90 to …
cytosolic nonhistone substrates, such as α-tubulin, cortactin, and heat shock protein 90 to …
HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma
Histone deacetylases are considered to be among the most promising targets in drug
development for cancer therapy. Histone deacetylase 6 (HDAC6) is a unique cytoplasmic …
development for cancer therapy. Histone deacetylase 6 (HDAC6) is a unique cytoplasmic …
Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways
J Cao, W Lv, L Wang, J Xu, P Yuan, S Huang… - Cell death & …, 2018 - nature.com
Abstract Ricolinostat (ACY-1215), a first-in-class selective HDAC6 inhibitor, exhibits
antitumor effects alone or in combination with other drugs in various cancers. However, its …
antitumor effects alone or in combination with other drugs in various cancers. However, its …